HOME DEPOT, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that HOME DEPOT, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2009 | Jan 31, 2010 | $66.18B | Mar 25, 2010 |
| FY2009 | Feb 1, 2009 | $71.29B | Mar 25, 2010 |
| FY2009 | Feb 3, 2008 | $77.35B | Mar 25, 2010 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 1, 2026 | $164.68B | Mar 18, 2026 |
| FY2025 | Feb 2, 2025 | $159.51B | Mar 18, 2026 |
| FY2025 | Jan 28, 2024 | $152.67B | Mar 18, 2026 |
| FY2024 | Jan 29, 2023 | $157.40B | Mar 21, 2025 |
| FY2023 | Jan 30, 2022 | $151.16B | Mar 13, 2024 |
| FY2022 | Jan 31, 2021 | $132.11B | Mar 15, 2023 |
| FY2019 | Feb 2, 2020 | $25.78B | Mar 25, 2020 |
| FY2019 | Nov 3, 2019 | $27.22B | Mar 25, 2020 |
| FY2019 | Aug 4, 2019 | $30.84B | Mar 25, 2020 |
| FY2019 | May 5, 2019 | $26.38B | Mar 25, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jan 28, 2018 | $23.88B | Mar 22, 2018 |
| FY2017 | Oct 29, 2017 | $25.03B | Mar 22, 2018 |
| FY2017 | Jul 30, 2017 | $28.11B | Mar 22, 2018 |
| FY2017 | Apr 30, 2017 | $23.89B | Mar 22, 2018 |
| FY2017 | Jan 29, 2017 | $22.21B | Mar 22, 2018 |
| FY2017 | Oct 30, 2016 | $23.15B | Mar 22, 2018 |
| FY2017 | Jul 31, 2016 | $26.47B | Mar 22, 2018 |
| FY2017 | May 1, 2016 | $22.76B | Mar 22, 2018 |
| FY2016 | Jan 31, 2016 | $20.98B | Mar 23, 2017 |
| FY2016 | Nov 1, 2015 | $21.82B | Mar 23, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 1, 2026 | $54.87B | Mar 18, 2026 |
| FY2025 | Feb 2, 2025 | $53.31B | Mar 18, 2026 |
| FY2025 | Jan 28, 2024 | $50.96B | Mar 18, 2026 |
| FY2024 | Jan 29, 2023 | $52.78B | Mar 21, 2025 |
| FY2023 | Jan 30, 2022 | $50.83B | Mar 13, 2024 |
| FY2022 | Jan 31, 2021 | $44.85B | Mar 15, 2023 |
| FY2019 | Feb 2, 2020 | $8.74B | Mar 25, 2020 |
| FY2019 | Nov 3, 2019 | $9.39B | Mar 25, 2020 |
| FY2019 | Aug 4, 2019 | $10.43B | Mar 25, 2020 |
| FY2019 | May 5, 2019 | $9.02B | Mar 25, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 1, 2026 | $14.16B | Mar 18, 2026 |
| FY2025 | Feb 2, 2025 | $14.81B | Mar 18, 2026 |
| FY2025 | Jan 28, 2024 | $15.14B | Mar 18, 2026 |
| FY2024 | Jan 29, 2023 | $17.11B | Mar 21, 2025 |
| FY2023 | Jan 30, 2022 | $16.43B | Mar 13, 2024 |
| FY2022 | Jan 31, 2021 | $12.87B | Mar 15, 2023 |
| FY2019 | Feb 2, 2020 | $2.48B | Mar 25, 2020 |
| FY2019 | Nov 3, 2019 | $2.77B | Mar 25, 2020 |
| FY2019 | Aug 4, 2019 | $3.48B | Mar 25, 2020 |
| FY2019 | May 5, 2019 | $2.51B | Mar 25, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 1, 2026 | $20.89B | Mar 18, 2026 |
| FY2025 | Feb 2, 2025 | $21.53B | Mar 18, 2026 |
| FY2025 | Jan 28, 2024 | $21.69B | Mar 18, 2026 |
| FY2024 | Jan 29, 2023 | $24.04B | Mar 21, 2025 |
| FY2023 | Jan 30, 2022 | $23.04B | Mar 13, 2024 |
| FY2022 | Jan 31, 2021 | $18.28B | Mar 15, 2023 |
| FY2021 | Feb 2, 2020 | $15.84B | Mar 23, 2022 |
| FY2020 | Feb 3, 2019 | $15.53B | Mar 24, 2021 |
| FY2019 | Jan 28, 2018 | $14.68B | Mar 25, 2020 |
| FY2018 | Jan 29, 2017 | $13.43B | Mar 28, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 1, 2026 | $30.70B | Mar 18, 2026 |
| FY2025 | Feb 2, 2025 | $28.75B | Mar 18, 2026 |
| FY2025 | Jan 28, 2024 | $26.60B | Mar 18, 2026 |
| FY2024 | Jan 29, 2023 | $26.28B | Mar 21, 2025 |
| FY2023 | Jan 30, 2022 | $25.41B | Mar 13, 2024 |
| FY2022 | Jan 31, 2021 | $24.45B | Mar 15, 2023 |
| FY2021 | Feb 2, 2020 | $19.74B | Mar 23, 2022 |
| FY2020 | Feb 3, 2019 | $19.51B | Mar 24, 2021 |
| FY2019 | Jan 28, 2018 | $17.86B | Mar 25, 2020 |
| FY2018 | Jan 29, 2017 | $17.13B | Mar 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 1, 2026 | $16.33B | Mar 18, 2026 |
| FY2025 | Feb 2, 2025 | $19.81B | Mar 18, 2026 |
| FY2025 | Jan 28, 2024 | $21.17B | Mar 18, 2026 |
| FY2024 | Jan 29, 2023 | $14.62B | Mar 21, 2025 |
| FY2023 | Jan 30, 2022 | $16.57B | Mar 13, 2024 |
| FY2022 | Jan 31, 2021 | $18.84B | Mar 15, 2023 |
| FY2021 | Feb 2, 2020 | $13.69B | Mar 23, 2022 |
| FY2020 | Feb 3, 2019 | $13.17B | Mar 24, 2021 |
| FY2019 | Jan 28, 2018 | $12.03B | Mar 25, 2020 |
| FY2018 | Jan 29, 2017 | $9.78B | Mar 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 1, 2026 | $105.10B | Mar 18, 2026 |
| FY2025 | Feb 2, 2025 | $96.12B | Mar 18, 2026 |
| FY2024 | Jan 28, 2024 | $76.53B | Mar 21, 2025 |
| FY2023 | Jan 29, 2023 | $76.45B | Mar 13, 2024 |
| FY2022 | Jan 30, 2022 | $71.88B | Mar 15, 2023 |
| FY2021 | Jan 31, 2021 | $70.58B | Mar 23, 2022 |
| FY2020 | Feb 2, 2020 | $51.24B | Mar 24, 2021 |
| FY2019 | Feb 3, 2019 | $44.00B | Mar 25, 2020 |
| FY2018 | Jan 28, 2018 | $44.53B | Mar 28, 2019 |
| FY2017 | Jan 29, 2017 | $42.97B | Mar 22, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 1, 2026 | $92.28B | Mar 18, 2026 |
| FY2025 | Feb 2, 2025 | $89.48B | Mar 18, 2026 |
| FY2024 | Jan 28, 2024 | $75.49B | Mar 21, 2025 |
| FY2023 | Jan 29, 2023 | $74.88B | Mar 13, 2024 |
| FY2022 | Jan 30, 2022 | $73.57B | Mar 15, 2023 |
| FY2021 | Jan 31, 2021 | $67.28B | Mar 23, 2022 |
| FY2020 | Feb 2, 2020 | $54.35B | Mar 24, 2021 |
| FY2019 | Feb 3, 2019 | $45.88B | Mar 25, 2020 |
| FY2018 | Jan 28, 2018 | $43.08B | Mar 28, 2019 |
| FY2017 | Jan 29, 2017 | $38.63B | Mar 22, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 1, 2026 | $12.81B | Mar 18, 2026 |
| FY2025 | Feb 2, 2025 | $6.64B | Mar 18, 2026 |
| FY2025 | Jan 28, 2024 | $1.04B | Mar 18, 2026 |
| FY2024 | Jan 29, 2023 | $1.56B | Mar 21, 2025 |
| FY2023 | Jan 30, 2022 | ($1.70B) | Mar 13, 2024 |
| FY2022 | Jan 31, 2021 | $3.30B | Mar 15, 2023 |
| FY2021 | Feb 2, 2020 | ($3.12B) | Mar 23, 2022 |
| FY2020 | Feb 3, 2019 | ($1.88B) | Mar 24, 2021 |
| FY2019 | Jan 28, 2018 | $1.45B | Mar 25, 2020 |
| FY2018 | Jan 29, 2017 | $4.33B | Mar 28, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 1, 2026 | $22.34B | Mar 18, 2026 |
| FY2025 | Feb 2, 2025 | $19.48B | Mar 18, 2026 |
| FY2025 | Jan 28, 2024 | $8.46B | Mar 18, 2026 |
| FY2024 | Jan 29, 2023 | $7.44B | Mar 21, 2025 |
| FY2023 | Jan 30, 2022 | $7.45B | Mar 13, 2024 |
| FY2022 | Jan 31, 2021 | $7.13B | Mar 15, 2023 |
| FY2021 | Feb 2, 2020 | $2.25B | Mar 23, 2022 |
| FY2020 | Feb 3, 2019 | $2.25B | Mar 24, 2021 |
| FY2019 | Jan 28, 2018 | $2.28B | Mar 25, 2020 |
| FY2019 | Jan 29, 2017 | $2.09B | Mar 25, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 1, 2026 | $94.54B | Mar 18, 2026 |
| FY2025 | Feb 2, 2025 | $89.53B | Mar 18, 2026 |
| FY2024 | Jan 28, 2024 | $83.66B | Mar 21, 2025 |
| FY2023 | Jan 29, 2023 | $76.90B | Mar 13, 2024 |
| FY2022 | Jan 30, 2022 | $67.58B | Mar 15, 2023 |
| FY2021 | Jan 31, 2021 | $58.13B | Mar 23, 2022 |
| FY2020 | Feb 2, 2020 | $51.73B | Mar 24, 2021 |
| FY2019 | Feb 3, 2019 | $46.42B | Mar 25, 2020 |
| FY2018 | Jan 28, 2018 | $39.94B | Mar 28, 2019 |
| FY2017 | Jan 29, 2017 | $35.52B | Mar 22, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 1, 2026 | $1.39B | Mar 18, 2026 |
| FY2025 | Feb 2, 2025 | $1.66B | Mar 18, 2026 |
| FY2024 | Jan 28, 2024 | $3.76B | Mar 21, 2025 |
| FY2023 | Jan 29, 2023 | $2.76B | Mar 13, 2024 |
| FY2022 | Jan 30, 2022 | $2.34B | Mar 15, 2023 |
| FY2021 | Jan 31, 2021 | $7.90B | Mar 23, 2022 |
| FY2020 | Feb 2, 2020 | $2.13B | Mar 24, 2021 |
| FY2019 | Feb 3, 2019 | $1.78B | Mar 25, 2020 |
| FY2019 | Jan 28, 2018 | $3.60B | Mar 25, 2020 |
| FY2019 | Jan 29, 2017 | $2.54B | Mar 25, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 1, 2026 | $49.40B | Mar 18, 2026 |
| FY2024 | Feb 2, 2025 | $51.37B | Mar 21, 2025 |
| FY2023 | Jan 28, 2024 | $42.15B | Mar 13, 2024 |
| FY2022 | Jan 29, 2023 | $41.15B | Mar 15, 2023 |
| FY2021 | Jan 30, 2022 | $36.40B | Mar 23, 2022 |
| FY2020 | Jan 31, 2021 | $34.75B | Mar 24, 2021 |
| FY2019 | Feb 2, 2020 | $29.50B | Mar 25, 2020 |
| FY2010 | Jan 30, 2011 | $9.75B | Mar 24, 2011 |
| FY2010 | Jan 31, 2010 | $9.68B | Mar 24, 2011 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 1, 2026 | 14 | Mar 18, 2026 |
| FY2025 | Feb 2, 2025 | 14 | Mar 18, 2026 |
| FY2025 | Jan 28, 2024 | 15 | Mar 18, 2026 |
| FY2024 | Jan 29, 2023 | 16 | Mar 21, 2025 |
| FY2023 | Jan 30, 2022 | 15 | Mar 13, 2024 |
| FY2022 | Jan 31, 2021 | 11 | Mar 15, 2023 |
| FY2019 | Feb 2, 2020 | 2 | Mar 25, 2020 |
| FY2019 | Nov 3, 2019 | 2 | Mar 25, 2020 |
| FY2019 | Aug 4, 2019 | 3 | Mar 25, 2020 |
| FY2019 | May 5, 2019 | 2 | Mar 25, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 1, 2026 | 14 | Mar 18, 2026 |
| FY2025 | Feb 2, 2025 | 14 | Mar 18, 2026 |
| FY2025 | Jan 28, 2024 | 15 | Mar 18, 2026 |
| FY2024 | Jan 29, 2023 | 16 | Mar 21, 2025 |
| FY2023 | Jan 30, 2022 | 15 | Mar 13, 2024 |
| FY2022 | Jan 31, 2021 | 11 | Mar 15, 2023 |
| FY2019 | Feb 2, 2020 | 2 | Mar 25, 2020 |
| FY2019 | Nov 3, 2019 | 2 | Mar 25, 2020 |
| FY2019 | Aug 4, 2019 | 3 | Mar 25, 2020 |
| FY2019 | May 5, 2019 | 2 | Mar 25, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 1, 2026 | 996.00M | Mar 18, 2026 |
| FY2025 | Feb 2, 2025 | 994.00M | Mar 18, 2026 |
| FY2025 | Jan 28, 2024 | 992.00M | Mar 18, 2026 |
| FY2024 | Jan 29, 2023 | 1.02B | Mar 21, 2025 |
| FY2023 | Jan 30, 2022 | 1.04B | Mar 13, 2024 |
| FY2022 | Jan 31, 2021 | 1.08B | Mar 15, 2023 |
| FY2021 | Feb 2, 2020 | 1.08B | Mar 23, 2022 |
| FY2020 | Feb 3, 2019 | 1.11B | Mar 24, 2021 |
| FY2019 | Jan 28, 2018 | 1.16B | Mar 25, 2020 |
| FY2018 | Jan 29, 2017 | 1.20B | Mar 28, 2019 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 1, 2026 | $9.15B | Mar 18, 2026 |
| FY2025 | Feb 2, 2025 | $8.93B | Mar 18, 2026 |
| FY2025 | Jan 28, 2024 | $8.38B | Mar 18, 2026 |
| FY2024 | Jan 29, 2023 | $7.79B | Mar 21, 2025 |
| FY2023 | Jan 30, 2022 | $6.99B | Mar 13, 2024 |
| FY2022 | Jan 31, 2021 | $6.45B | Mar 15, 2023 |
| FY2021 | Feb 2, 2020 | $5.96B | Mar 23, 2022 |
| FY2020 | Feb 3, 2019 | $4.70B | Mar 24, 2021 |
| FY2019 | Jan 28, 2018 | $4.21B | Mar 25, 2020 |
| FY2018 | Jan 29, 2017 | $3.40B | Mar 28, 2019 |